George Gauthier Igm Biosciences, Inc. (IGMS) insider trading activity

George Gauthier is Chief Commercial Officer of IGM Biosciences, Inc.. Currently has a direct ownership of 39,642 shares of IGMS, which is worth approximately $239,834. The most recent transaction as insider was on Nov 29, 2023, when has been sold 1,180 shares (Common Stock) at a price of $6.21 per share, resulting in proceeds of $7,327. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.6K

0% 3M change

0% 12M change

Total Value Held $239,834

George Gauthier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2023	SELL Open market or private sale	$7,327 $6.21 p/Share	1,180 Reduced 2.89%	39,642 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$8,734 $5.02 p/Share	1,740 Added 4.09%	40,822 Common Stock
Oct 02 2023	SELL Open market or private sale	$7,433 $7.95 p/Share	935 Reduced 2.34%	39,082 Common Stock
Jul 03 2023	SELL Open market or private sale	$8,817 $9.42 p/Share	936 Reduced 2.29%	40,017 Common Stock
May 23 2023	SELL Open market or private sale	$15,938 $12.66 p/Share	1,259 Reduced 2.98%	40,953 Common Stock
Apr 18 2023	BUY Grant, award, or other acquisition	-	8,334 Added 16.49%	42,212 Common Stock
Apr 05 2023	SELL Open market or private sale	$11,781 $12.6 p/Share	935 Reduced 2.69%	33,878 Common Stock
Apr 04 2023	BUY Grant, award, or other acquisition	-	16,250 Added 31.82%	34,813 Common Stock
Mar 14 2023	SELL Open market or private sale	$19,872 $18.73 p/Share	1,061 Reduced 5.41%	18,563 Common Stock
Dec 16 2022	SELL Open market or private sale	$83,030 $19.07 p/Share	4,354 Reduced 18.16%	19,624 Common Stock
Nov 23 2022	SELL Open market or private sale	$27,273 $21.68 p/Share	1,258 Reduced 4.98%	23,978 Common Stock
May 24 2022	SELL Open market or private sale	$22,914 $17.1 p/Share	1,340 Reduced 5.04%	25,236 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$5,113 $12.38 p/Share	413 Added 1.53%	26,576 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	8,096 Added 23.63%	26,163 Common Stock
Mar 12 2022	BUY Grant, award, or other acquisition	-	7,500 Added 29.33%	18,067 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	10,000 Added 48.62%	10,567 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$18,713 $50.99 p/Share	367 Added 39.29%	567 Common Stock

George Gauthier

Chief Commercial Officer

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Value

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS

Account